期刊
CHEST
卷 160, 期 6, 页码 2232-2246出版社
ELSEVIER
DOI: 10.1016/j.chest.2021.08.039
关键词
KEY WORDS; diastolic heart failure; heart failure with preserved ejection fraction; left heart disease; pulmonary hypertension; right ventricle
HFpEF, the most common form of heart failure, is often associated with PH, which may be difficult to distinguish from different forms of PH but accurate diagnosis is crucial for divergent therapeutic pathways. HFpEF associated with PH can be subdivided into IpcPH and CpcPH, with the latter having a worse prognosis.
Heart failure with preserved ejection fraction (HFpEF) is the most common form of heart failure and frequently is associated with pulmonary hypertension (PH). HFpEF associated with PH may be difficult to distinguish from precapillary forms of PH, although this distinction is crucial because therapeutic pathways are divergent for the two conditions. A comprehensive and systematic approach using history, clinical examination, and noninvasive and invasive evaluation with and without provocative testing may be necessary for accurate diagnosis and phenotyping. After diagnosis, HFpEF associated with PH can be subdivided into isolated postcapillary pulmonary hypertension (IpcPH) and combined postcapillary and precapillary pulmonary hypertension (CpcPH) based on the presence or absence of elevated pulmonary vascular resistance. CpcPH portends a worse prognosis than IpcPH. Despite its association with reduced functional capacity and quality of life, heart failure hospitalizations, and higher mortality, therapeutic options focused on PH for HFpEF associated with PH remain limited. In this review, we aim to provide an updated overview on clinical definitions and hemodynamically characterized phenotypes of PH, pathophysiologic features, therapeutic strategies, and ongoing challenges in this patient population. CHEST 2021; 160(6):2232-2246
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据